HLTH4011 Issues in Health Care: HPV Vaccination Presentation, TRU

This poster presentation, created for HLTH4011 Issues in Health Care, Module 2, at TRU Open Learning, provides an environmental scan on human papillomavirus (HPV) vaccination in the Canadian context. The presentation outlines the health issue, including the different types of HPV and their potential health consequences like genital warts and cancer, and identifies the groups impacted. It discusses the principles of the Canada Health Act affected by HPV vaccination initiatives. The presentation details the current approaches to address the issue, including the use of Gardasil and other HPV vaccines recommended by the National Advisory Committee on Immunization, as well as global efforts by WHO. The references include sources such as canada.ca and who.int, providing a comprehensive overview of the topic.

HLTH4011 Issues in Health Care: Module 2 - Health care in the Canadian Context 1
Poster Presentation
TRU Open Learning

2 Week 6: The Future is Bright – Or is it?
Environmental scanning as a public health tool
Title:
Your Name:
Course Name:
TRU Open Learning
Purpose
The purpose of this project is to conduct an
environmental scanning on a human papillomavirus
vaccination
Principles of the Canada Health Act being impacted
Since the discovery of the HPV, Canada began the
vaccinations procedures so as to prevent the spread of
HPV and the increase in the rates of cancer due to it
(canada.ca 2019).
Discussion of the issue
including the context
There are more than 200 types of the HPV
and 40 different types infect the genital area
as well as the throat and the mouth area. The
different kinds of the HPV are spread
through the sexual contact while there are
also other types of HPV that can cause the
warts on hands and feet and they are not
transmitted sexually. Most of the genital
warts are not harmful and they go away on
their own, however there are certain other
types that lead to cancer or can cause genital
warts. The two major types of the HPV are
the types 11 and types 6 and both of them
causes the genital warts. These are the low
risk HPV and the best part is that they do
not cause serious health issues and they do
not cause cancer. There is also a dozen of
the HPV that lead to causing cancer and the
two major types are the type 18 and types
16. These are called the high risk HPV and
they can potentially cause cervical cancer
along with cancer is areas like throat and
mouth (Nichols et al. 2013
).
References
canada.ca, 2019. Human papillomavirus (HPV) -
Canada.ca. [online] Canada.ca. Available at:
https://www.canada.ca/en/public-health/services/disease
s/human-papillomavirus-hpv.html [Accessed 13 Mar.
2019].
Drolet, M., Laprise, J.F., Boily, M.C., Franco, E.L. and
Brisson, M., 2014. Potential cost‐effectiveness of the
nonavalent human papillomavirus (HPV) vaccine.
International journal of cancer, 134(9), pp.2264-2268.
Nichols, A.C., Palma, D.A., Dhaliwal, S.S., Tan, S.,
Theuer, J., Chow, W., Rajakumar, C., Um, S., Mundi,
N., Berk, S. and Zhou, R., 2013. The epidemic of
human papillomavirus and oropharyngeal cancer in a
Canadian population. Current oncology, 20(4), p.212.
who.int, 2019. WHO | Human papillomavirus and HPV
vaccines: a review. [online] Who.int. Available at:
https://www.who.int/bulletin/volumes/85/9/06-038414/e
n/ [Accessed 13 Mar. 2019].
Who is being impacted?
Both the males and the females of the age group of
18 to 60 gets infected by the HPV.
Overview of Health Issue
HPV stands for the human papillomavirus and it is
considered to be one of the most commonly sexually
transmitted infection. It is important to mention that
that the HPV is actually harmless but it goes away,
however some types can cause genital warts and also
can lead to cancer (Drolet et al. 2014).
Information: What is being done
about the issue?
The National Advisory Committee on Immunization
recommended on the usage of Gardsil for the females
that are aged 9 to 26. While Gardsil was recommended
for the males that are aged from 9 to 26 and females that
are aged 27 to 45. This also included the vaccine
Ceravix for the females. In the year 2016, a new vaccine
was included which is called Gardsil 9 that was later on
authorized to be used in Canada (canada.ca 2019).
At the global level, WHO has issued the 3 different
vaccines that will be working against the HPV 16 and
HPV 18. The third type of the vaccine provides
protection against the other types of oncogenic HPV.
The vaccines are the only way of protecting the HPV 16
and 18. WHO equally considers the three vaccines to be
protective against the cervical cancer (who.int 2019).